Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

Two nutritional supplements improved hair growth and reduced hair loss in women with hair loss conditions.

The study confirmed that changes in hair structure in women with hair loss conditions matched what is taught in beauty college trichology courses.

Androgenetic alopecia, a common hair loss condition, can affect mental health and there are various medical treatments available for it.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Changing Wnt signaling can lead to more or less hair growth and might help treat hair loss and skin conditions.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

COVID-19 can cause a temporary hair loss condition.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Platelet-rich plasma can help treat hair loss condition called alopecia areata.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Herbal treatments are effective and preferred for hair loss with fewer side effects.